JPH06506706A - ベンゾフルメトールを含有する抗マラリア性の相乗作用組成物 - Google Patents
ベンゾフルメトールを含有する抗マラリア性の相乗作用組成物Info
- Publication number
- JPH06506706A JPH06506706A JP5513710A JP51371093A JPH06506706A JP H06506706 A JPH06506706 A JP H06506706A JP 5513710 A JP5513710 A JP 5513710A JP 51371093 A JP51371093 A JP 51371093A JP H06506706 A JPH06506706 A JP H06506706A
- Authority
- JP
- Japan
- Prior art keywords
- effective amount
- quinine
- pharmaceutically acceptable
- synergistically effective
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (8)
- 1.マラリアに対し複数の活性成分の相乗作用に適した医薬組成物であって、 次式I: ▲数式、化学式、表等があります▼(I),の化合物の相乗作用的に有効な量と 、 キニン、メフロキニン、ハロファントリン、クロロキニン、プリマキニンおよび ピロナリジンから成る群から選ばれる少なくとも1種の化合物又は抗マラリア効 能を有する、それらの医薬として許容し得る塩もしくは誘導体の相乗作用的に有 効な量を含んでなる、前記医薬組成物。
- 2.ベンフルメトール(I)の相乗作用的に有効な量と、キニン、メフロキニン およびハロファントリンから成る群から選ばれる少なくとも1種の化合物又は抗 マラリア効能を有するそれらの医薬として許容し得る塩もしくは誘導体の相乗作 用的に有効な量を含んでなる、請求項1に記載の医薬組成物。
- 3.相乗作用的に有効な量のベンフルメトール(I)と、相乗作用的に有効な量 のキニン(II)の医薬として許容し得る塩を含んでなる、請求の範囲第1項に 記載の医薬組成物。
- 4.請求項1に係る医薬組成物の製造方法であって、ベンフルメトール(I)の 相乗作用的に有効な量と、キニン、メフロキニン、ハロファントリン、クロロキ ニン、プリアキニンおよびピロナリジンから成る群(II)から選ばれる少なく とも1種の化合物又はそれらの医薬として許容し得る塩もしくは誘導体の相乗作 用的に有効な量を組合せ、次いで医薬として許容し得る添加剤の任意の添加のも と、活性成分の該組合せ物を適当な投薬形態に製剤化することを含んでなる、前 記方法。
- 5.相乗作用的に有効な量のベンフルメトール(I)を、相乗作用的に有効な量 のキニンの医薬として許容し得る塩と組合せることを含んでなる、請求の範囲第 4項に記載の方法。
- 6.固体添加剤を錠剤に添加のもと、活性成分の組合せ物を製剤化することを含 んでなる、請求の範囲第4項に記載の方法。
- 7.医薬組成物の調製に対し、ベンフルメトール(I)の相乗作用的に有効な量 と、キニン、メフロキニン、ハロファントリン、クロロキニン、プリマキニンお よびピロナリジン又はそれらの医薬として許容し得る塩もしくは誘導体の相乗作 用的に有効な量とを含んでなる組合せ物の使用。
- 8.マラリアに対する治療に於て使用するための請求の範囲第1項に係る医薬組 成物。
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE92810089.0 | 1992-02-07 | ||
EP92810089 | 1992-02-07 | ||
EP92810130 | 1992-02-21 | ||
DE92810130.2 | 1992-02-21 | ||
PCT/EP1993/000163 WO1993015727A1 (en) | 1992-02-07 | 1993-01-25 | Antimalarial synergistic compositions containing benflumetol |
SG1996001151A SG45193A1 (en) | 1992-02-07 | 1993-01-25 | Antimalarial synergistic compositions containing benflumetol |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06506706A true JPH06506706A (ja) | 1994-07-28 |
JP3560970B2 JP3560970B2 (ja) | 2004-09-02 |
Family
ID=27234886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51371093A Expired - Lifetime JP3560970B2 (ja) | 1992-02-07 | 1993-01-25 | ベンゾフルメトールを含有する抗マラリア性の相乗作用組成物 |
Country Status (9)
Country | Link |
---|---|
JP (1) | JP3560970B2 (ja) |
CN (1) | CN1087168C (ja) |
AU (1) | AU668376B2 (ja) |
CA (1) | CA2105773A1 (ja) |
FI (1) | FI934360A (ja) |
HU (1) | HU220605B1 (ja) |
NZ (1) | NZ246606A (ja) |
SG (1) | SG45193A1 (ja) |
WO (1) | WO1993015727A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020517660A (ja) * | 2017-04-24 | 2020-06-18 | ノバルティス アーゲー | 2−アミノ−l−(2−(4−フルオロフェニル)−3−(4−フルオロフェニルアミノ)−8,8−ジメチル−5,6−ジヒドロイミダゾ[1,2−a]ピラジン−7(8h)−イル)エタノン及びそれらの組み合わせの治療レジメン |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9622427D0 (en) * | 1996-10-28 | 1997-01-08 | Pharma Mar Sa | Antimalarial drugs |
CN1109546C (zh) * | 1998-06-17 | 2003-05-28 | 中国疾病预防控制中心寄生虫病预防控制研究所 | 青蒿素类药物与咯萘啶的复方制剂抗疟药物 |
WO2001091535A2 (en) * | 2000-05-31 | 2001-12-06 | Nicholas Piramal India Limited | A combination kit used in the treatment of malaria containing chloroquine and 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone enthält |
JP4733918B2 (ja) * | 2003-10-01 | 2011-07-27 | オリンパス株式会社 | カプセル投薬システム |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN166154B (ja) * | 1987-05-08 | 1990-03-24 | Hoechst India | |
ES2054975T3 (es) * | 1988-10-07 | 1994-08-16 | Hoechst Ag | Composiciones antimalaricas que emplean quinidina, artemisinina y sus derivados. |
CN1058717A (zh) * | 1990-08-08 | 1992-02-19 | 中国人民解放军军事医学科学院微生物流行病研究所 | 抗疟新药—复方蒿甲醚及其制备方法 |
-
1993
- 1993-01-25 CA CA002105773A patent/CA2105773A1/en not_active Abandoned
- 1993-01-25 AU AU33522/93A patent/AU668376B2/en not_active Expired
- 1993-01-25 SG SG1996001151A patent/SG45193A1/en unknown
- 1993-01-25 WO PCT/EP1993/000163 patent/WO1993015727A1/en active IP Right Grant
- 1993-01-25 HU HU9303152A patent/HU220605B1/hu unknown
- 1993-01-25 NZ NZ246606A patent/NZ246606A/en not_active IP Right Cessation
- 1993-01-25 JP JP51371093A patent/JP3560970B2/ja not_active Expired - Lifetime
- 1993-02-06 CN CN93101341A patent/CN1087168C/zh not_active Expired - Lifetime
- 1993-10-04 FI FI934360A patent/FI934360A/fi unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020517660A (ja) * | 2017-04-24 | 2020-06-18 | ノバルティス アーゲー | 2−アミノ−l−(2−(4−フルオロフェニル)−3−(4−フルオロフェニルアミノ)−8,8−ジメチル−5,6−ジヒドロイミダゾ[1,2−a]ピラジン−7(8h)−イル)エタノン及びそれらの組み合わせの治療レジメン |
Also Published As
Publication number | Publication date |
---|---|
AU3352293A (en) | 1993-09-03 |
CA2105773A1 (en) | 1993-08-08 |
FI934360A0 (fi) | 1993-10-04 |
CN1087168C (zh) | 2002-07-10 |
AU668376B2 (en) | 1996-05-02 |
HU220605B1 (hu) | 2002-03-28 |
NZ246606A (en) | 1995-09-26 |
FI934360A (fi) | 1993-10-04 |
JP3560970B2 (ja) | 2004-09-02 |
SG45193A1 (en) | 1998-01-16 |
CN1075254A (zh) | 1993-08-18 |
WO1993015727A1 (en) | 1993-08-19 |
HUT66452A (en) | 1994-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5677331A (en) | Antimalarial compositions | |
JPS62292720A (ja) | 制御放出型ジヒドロコデイン組成物 | |
KR20010075021A (ko) | 불법적 용도로서 부적합한 교감신경흥분성 아민 염을포함하는 조성물 | |
DE3719818A1 (de) | Pharmazeutische zusammensetzungen | |
EP0277352B1 (de) | Synergistische Kombination von Azelastin und Theophyllin oder Azelastin und Beta-Mimetika | |
WO2005034936A1 (fr) | Utilisation de l-butylphtalide dans la fabrication de medicaments destines a la prevention et au traitement de l'infarctus cerebral | |
JPS604802B2 (ja) | 制癌剤 | |
JPH06506706A (ja) | ベンゾフルメトールを含有する抗マラリア性の相乗作用組成物 | |
EP1655029B1 (en) | Medicinal compositions | |
US6300343B1 (en) | Method of treatment | |
DE10392718T5 (de) | Pharmazeutische Formulierung in einem Medikamentenfreisetzungssystem und Verfahren zur Herstellung derselben | |
KR20230145439A (ko) | Irak4 분해제 및 이의 용도 | |
US20050069584A1 (en) | Diphenhydramine tannate solid dose compositions and methods of use | |
CN105147709B (zh) | 一种替诺福韦二吡呋酯或其药用盐的用途 | |
DE3736866A1 (de) | Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz | |
US5637594A (en) | Antimalarial synergistic compositions containing benflumetol | |
WO2014132226A1 (en) | Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereof | |
EP0583439B1 (en) | Antimalarial synergistic compositions containing benflumetol | |
US3495005A (en) | Compositions and methods for suppressing appetite with combinations of amphetamine and thioridazine | |
US4188404A (en) | Treatment of symptoms of aging | |
JPH09507499A (ja) | 5−ニトロイミダゾール誘導体の微粒剤 | |
EA042299B1 (ru) | Фармацевтические композиции и их применения | |
JPH05301816A (ja) | 抗エイズ剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040427 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040527 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090604 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100604 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110604 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110604 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120604 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120604 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130604 Year of fee payment: 9 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130604 Year of fee payment: 9 |